Carbamazepine Capsule, Extended Release — FDA Drug Shortage
The FDA lists a drug shortage record for Carbamazepine Capsule, Extended Release (capsule, extended release) from Takeda Pharmaceuticals USA Inc. with status To Be Discontinued. The shortage was first posted on Dec 19, 2025.
Shortage details
- Status
- To Be Discontinued
- Company
- Takeda Pharmaceuticals USA Inc.
- Package NDC
- 54092-173-12
- Dosage Form
- Capsule, Extended Release
- Presentation
- Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)
- Initial Posting
- Dec 19, 2025